A COMPARATIVE STUDY OF VIDANGADI VATI AND BHARANGYADI VATI IN THE MANAGEMENT OF TAMAK SHWASA W.S.R TO BRONCHIAL ASTHMA

Dr. Shital Bhagiya
2017 World Journal of Pharmaceutical Research  
As prevalence of Asthma is increasing steadily over the lateral part of the last century, first in the developed and developing world. Today's life is running so fast that people can't follow Dincharaya and Ritucharya which has been described in our texts and therefore, patients with chronic airway disorders like Shwasa are increasing. Acharya Charaka mentioned Shwasa as Ashivisha like, Pranhara and Paramdurjaya Vyadhi, Therefore its early management has been stressed so that patient may not be
more » ... patient may not be distressed by chronicity of Shwasa. Therefor the study was aimed to study etiopathogenesis, symptomatology and epidemiology of the Tamakshwasa and to assess efficacy of Vidangadi vati and Bharangyadi vati in the management of Tamakshwasa. Method: Thirty patients suffering from Tamakshwasa (Bronchial Asthma) between the age group of 16 to 60 years of either sex participated in the study. Study was a randomized, controlled, open label clinical study. Patients were randomly divided into two groups: Group A (n = 15) received Vidangadivati, 4 tab-tds (500mg for 1 tab.) for 6 weeks with Ushnajala. Group B (n = 15) Bharangyadivati with same dose and duration. Assessments were done after six weeks in both groups. Result: In Group A moderate response was found in 53.33% of cases, mild improvement in 26.66% of cases and 20% of patients had no relief. In Group B moderate response was found in 60% of cases, mild improvement in 26.66% of cases and 13.33% of patients had no relief. Conclusion: Study showed that Vidangadi vati is more effective in Tamakshwas then Bharngyadi vati.
doi:10.20959/wjpr20175-8287 fatcat:hywgsuk6pfdc5lr3yvftbjqaoe